The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Mehta Kishan | Director | Gift(G) | 17K | — | $0 |
| Mar 17, 2026 | Mehta Kishan | Director | Gift(G) | 17K | — | $0 |
| Feb 27, 2026 | Gentile Kimberly | SVP, Clinical Operations | Grant(A) | 175K | — | $0 |
| Feb 27, 2026 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 550K | — | $0 |
| Feb 27, 2026 | Car Bruce | Chief Scientific Officer | Grant(A) | 175K | — | $0 |
| Feb 27, 2026 | Clark George C. | VP, Chief Accounting Officer | Grant(A) | 50K | — | $0 |
| Feb 27, 2026 | Buten Matthew | Chief Financial Officer | Grant(A) | 175K | — | $0 |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | Tax withholding(F) | 2K | $9.93 | $19K |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer, Director | Tax withholding(F) | 7K | $9.93 | $74K |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | Tax withholding(F) | 2K | $9.93 | $24K |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | Option exercise(M) | 3K | — | $0 |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | Tax withholding(F) | 1K | $9.93 | $11K |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | Option exercise(M) | 3K | — | $0 |
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | Tax withholding(F) | 3K | $9.93 | $26K |
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Nov 17, 2025 | Clark George C. | VP, Chief Accounting Officer | Buy(P) | 17K | $8.52 | $145K |
| Nov 13, 2025 | Childs John W | Director | Buy(P) | 3.3M | $7.50 | $25.0M |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer, Director | Buy(P) | 333K | $7.50 | $2.5M |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer, Director | Buy(P) | 333K | $7.50 | $2.5M |
| Nov 13, 2025 | Bailey Gregory | Director | Buy(P) | 400K | $7.50 | $3.0M |
| May 5, 2025 | Hugin Robert J | Director | Grant(A) | 32K | — | $0 |
| May 5, 2025 | Childs John W | Director | Grant(A) | 32K | — | $0 |
| May 5, 2025 | Gregory Julia P | Director | Grant(A) | 32K | — | $0 |
| May 5, 2025 | Mehta Kishan | Director | Grant(A) | 32K | — | $0 |
| May 5, 2025 | Bailey Gregory | Director | Grant(A) | 32K | — | $0 |
| May 5, 2025 | Heffernan Michael Thomas | Director | Grant(A) | 32K | — | $0 |
| May 5, 2025 | Antonijevic Irina | Director | Grant(A) | 32K | — | $0 |
| Mar 4, 2025 | Childs John W | Director | Buy(P) | 28K | $30.43 | $864K |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer, Director | Tax withholding(F) | 7K | $38.64 | $263K |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 343K | — | $0 |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 57K | — | $0 |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Tax withholding(F) | 3K | $38.64 | $99K |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Grant(A) | 17K | — | $0 |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Grant(A) | 104K | — | $0 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Tax withholding(F) | 1K | $38.64 | $43K |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Option exercise(M) | 3K | — | $0 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Option exercise(M) | 3K | — | $0 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Grant(A) | 10K | — | $0 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Grant(A) | 30K | — | $0 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Tax withholding(F) | 2K | $38.64 | $76K |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Option exercise(M) | 4K | — | $0 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Grant(A) | 91K | — | $0 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Grant(A) | 15K | — | $0 |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Tax withholding(F) | 2K | $38.64 | $90K |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Grant(A) | 112K | — | $0 |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Grant(A) | 19K | — | $0 |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Dec 30, 2024 | Childs John W | Director | Buy(P) | 29K | $35.94 | $1.0M |
| Oct 2, 2024 | Coric Vlad | Chief Executive Officer, Director | Buy(P) | 21K | $47.50 | $1000K |
| Oct 2, 2024 | Childs John W | Director | Buy(P) | 21K | $47.50 | $1000K |
| Sep 24, 2024 | Bailey Gregory | Director | Buy(P) | 5K | $44.19 | $221K |
| Jul 18, 2024 | Childs John W | Director | Buy(P) | 28K | $35.67 | $1.0M |
| Jun 17, 2024 | Car Bruce | Chief Scientific Officer | Buy(P) | 30K | $33.58 | $1.0M |
| May 30, 2024 | Childs John W | Director | Buy(P) | 28K | $35.58 | $996K |
| May 13, 2024 | Childs John W | Director | Buy(P) | 29K | $35.17 | $1.0M |
| May 13, 2024 | Bailey Gregory | Director | Buy(P) | 15K | $34.19 | $513K |
| Apr 30, 2024 | Bailey Gregory | Director | Grant(A) | 17K | — | $0 |
| Apr 30, 2024 | Childs John W | Director | Grant(A) | 17K | — | $0 |
| Apr 30, 2024 | Antonijevic Irina | Director | Grant(A) | 17K | — | $0 |
| Apr 30, 2024 | Hugin Robert J | Director | Grant(A) | 17K | — | $0 |
| Apr 30, 2024 | Gregory Julia P | Director | Grant(A) | 17K | — | $0 |
| Apr 30, 2024 | Heffernan Michael Thomas | Director | Grant(A) | 17K | — | $0 |
| Apr 30, 2024 | Mehta Kishan | Director | Grant(A) | 17K | — | $0 |
| Apr 24, 2024 | Bailey Gregory | Director | Buy(P) | 26K | $39.18 | $999K |
| Apr 22, 2024 | Childs John W | Director | Buy(P) | 73K | $41.00 | $3.0M |
| Apr 22, 2024 | Coric Vlad | Chief Executive Officer, Director | Buy(P) | 122K | $41.00 | $5.0M |
| Apr 22, 2024 | Bailey Gregory | Director | Buy(P) | 49K | $41.00 | $2.0M |
| Apr 5, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 231 | — | — |
| Apr 5, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 232 | — | — |
| Apr 5, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 231 | — | — |
| Apr 5, 2024 | Childs John W | Director | Grant(A) | 2K | — | — |
| Mar 8, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 2K | — | — |
| Mar 8, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 2K | — | — |
| Mar 8, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 2K | — | — |
| Mar 8, 2024 | Childs John W | Director | Grant(A) | 19K | — | — |
| Jan 8, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 5K | — | — |
| Jan 8, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 5K | — | — |
| Jan 8, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 5K | — | — |
| Jan 8, 2024 | Childs John W | Director | Other(J) | 49K | — | — |
| Jan 2, 2024 | Coric Vlad | Chief Executive Officer, Director | Grant(A) | 275K | — | $0 |
| Jan 2, 2024 | Buten Matthew | Chief Financial Officer | Grant(A) | 96K | — | $0 |
| Jan 2, 2024 | Gentile Kimberly | SVP, Clinical Operations | Grant(A) | 96K | — | $0 |
| Jan 2, 2024 | Car Bruce | Chief Scientific Officer | Grant(A) | 96K | — | $0 |
| Jan 2, 2024 | Clark George C. | VP, Chief Accounting Officer | Grant(A) | 28K | — | $0 |
| Dec 29, 2023 | Antonijevic Irina | Director | Option exercise(M) | 11K | — | $0 |
| Dec 29, 2023 | Antonijevic Irina | Director | Sell(S) | 11K | $41.79 | $460K |
| Dec 29, 2023 | Antonijevic Irina | Director | Option exercise(M) | 11K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).